# Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.

> **NCT00192426** · PHASE3 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 2400 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** CAIV-T

## Key facts

- **NCT ID:** NCT00192426
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** —
- **Final completion:** 2001-12
- **Target enrollment:** 2400 (—)
- **Last updated:** 2006-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192426, "Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00192426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*